Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model

Background—Obesity and diabetes mellitus are important metabolic risk factors and frequent comorbidities in heart failure with preserved ejection fraction. They contribute to myocardial diastolic dysfunction (DD) through collagen deposition or titin modification. The relative importance for myocardial DD of collagen deposition and titin modification was investigated in obese, diabetic ZSF1 rats after heart failure with preserved ejection fraction development at 20 weeks. Methods and Results—Four groups of rats (Wistar-Kyoto, n=11; lean ZSF1, n=11; obese ZSF1, n=11, and obese ZSF1 with high-fat diet, n=11) were followed up for 20 weeks with repeat metabolic, renal, and echocardiographic evaluations and hemodynamically assessed at euthanization. Myocardial collagen, collagen cross-linking, titin isoforms, and phosphorylation were also determined. Resting tension (Fpassive)–sarcomere length relations were obtained in small muscle strips before and after KCl–KI treatment, which unanchors titin and allows contributions of titin and extracellular matrix to Fpassive to be discerned. At 20 weeks, the lean ZSF1 group was hypertensive, whereas both obese ZSF1 groups were hypertensive and diabetic. Only the obese ZSF1 groups had developed heart failure with preserved ejection fraction, which was evident from increased lung weight, preserved left ventricular ejection fraction, and left ventricular DD. The underlying myocardial DD was obvious from high muscle strip stiffness, which was largely (±80%) attributable to titin hypophosphorylation. The latter occurred specifically at the S3991 site of the elastic N2Bus segment and at the S12884 site of the PEVK segment. Conclusions—Obese ZSF1 rats developed heart failure with preserved ejection fraction during a 20-week time span. Titin hypophosphorylation importantly contributed to the underlying myocardial DD.

[1]  W. Linke,et al.  Differential changes in titin domain phosphorylation increase myofilament stiffness in failing human hearts. , 2013, Cardiovascular research.

[2]  W. Linke,et al.  Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. , 2013, Cardiovascular research.

[3]  W. Linke,et al.  Crucial Role for Ca2+/Calmodulin-Dependent Protein Kinase-II in Regulating Diastolic Stress of Normal and Failing Hearts via Titin Phosphorylation , 2013, Circulation research.

[4]  R. Brook,et al.  Low-Sodium Dietary Approaches to Stop Hypertension Diet Reduces Blood Pressure, Arterial Stiffness, and Oxidative Stress in Hypertensive Heart Failure With Preserved Ejection Fraction , 2012, Hypertension.

[5]  J. Bronzwaer,et al.  Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction , 2012, Circulation.

[6]  A. McCulloch,et al.  A Novel Mechanism Involving Four-and-a-half LIM Domain Protein-1 and Extracellular Signal-regulated Kinase-2 Regulates Titin Phosphorylation and Mechanics* , 2012, The Journal of Biological Chemistry.

[7]  F. Fedele,et al.  Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy: A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging , 2012, Circulation.

[8]  Sameer Ather,et al.  Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. , 2012, Journal of the American College of Cardiology.

[9]  R. Nishimura,et al.  Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. , 2012, Journal of the American College of Cardiology.

[10]  W. Linke,et al.  Sildenafil and B-Type Natriuretic Peptide Acutely Phosphorylate Titin and Improve Diastolic Distensibility In Vivo , 2011, Circulation.

[11]  R. McKelvie,et al.  Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction , 2011, Circulation.

[12]  W. Paulus,et al.  Diabetes Mellitus Worsens Diastolic Left Ventricular Dysfunction in Aortic Stenosis Through Altered Myocardial Structure and Cardiomyocyte Stiffness , 2011, Circulation.

[13]  B. Massie,et al.  Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial , 2011, Circulation. Heart failure.

[14]  Frank Edelmann,et al.  Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction , 2011, Clinical Research in Cardiology.

[15]  W. Paulus,et al.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. , 2011, European heart journal.

[16]  H. Brunner-La Rocca,et al.  Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. , 2010, Journal of the American College of Cardiology.

[17]  W. Paulus Culprit Mechanism(s) for Exercise Intolerance in Heart Failure With Normal Ejection Fraction. , 2010, Journal of the American College of Cardiology.

[18]  Amir Lerman,et al.  Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. , 2010, Journal of the American College of Cardiology.

[19]  M. LeWinter,et al.  Cardiac titin: a multifunctional giant. , 2010, Circulation.

[20]  W. Paulus,et al.  Treatment of heart failure with normal ejection fraction: an inconvenient truth! , 2010, Journal of the American College of Cardiology.

[21]  J. Oh,et al.  Doppler echocardiography: a contemporary review. , 2009, Journal of cardiology.

[22]  Siegfried Labeit,et al.  PKC Phosphorylation of Titin’s PEVK Element: A Novel and Conserved Pathway for Modulating Myocardial Stiffness , 2009, Circulation research.

[23]  W. Linke,et al.  Titin-based mechanical signalling in normal and failing myocardium. , 2009, Journal of molecular and cellular cardiology.

[24]  J. Bronzwaer,et al.  Hypophosphorylation of the Stiff N2B Titin Isoform Raises Cardiomyocyte Resting Tension in Failing Human Myocardium , 2009, Circulation research.

[25]  C. Tschöpe,et al.  Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure , 2009, Basic Research in Cardiology.

[26]  Christian Andresen,et al.  Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs , 2008, Circulation research.

[27]  R. McKelvie,et al.  Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I‐PRESERVE trial , 2008, European journal of heart failure.

[28]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[29]  Wolfgang A. Linke,et al.  Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension , 2006, Journal of Muscle Research & Cell Motility.

[30]  Mark C Leake,et al.  Mechanical properties of cardiac titin's N2B-region by single-molecule atomic force spectroscopy. , 2006, Journal of structural biology.

[31]  Wolfgang A Linke,et al.  Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure , 2006, Circulation.

[32]  G. Aurigemma,et al.  Left Ventricular Systolic Performance, Function, and Contractility in Patients With Diastolic Heart Failure , 2005, Circulation.

[33]  Yiming Wu,et al.  Phosphorylation of Titin Modulates Passive Stiffness of Cardiac Muscle in a Titin Isoform-dependent Manner , 2005, The Journal of general physiology.

[34]  Arantxa González,et al.  Increased Collagen Type I Synthesis in Patients With Heart Failure of Hypertensive Origin: Relation to Myocardial Fibrosis , 2004, Circulation.

[35]  H. Granzier,et al.  Protein Kinase A Phosphorylates Titin’s Cardiac-Specific N2B Domain and Reduces Passive Tension in Rat Cardiac Myocytes , 2002, Circulation research.

[36]  S. Bastacky,et al.  RENAL FUNCTION AND STRUCTURE IN DIABETIC, HYPERTENSIVE, OBESE ZDFxSHHF-HYBRID RATS , 2000, Renal failure.

[37]  T. Irving,et al.  Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. , 1995, Biophysical journal.

[38]  M. Roberts,et al.  Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. , 1988, Journal of the American College of Cardiology.

[39]  J. Bronzwaer,et al.  Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension , 2008, Circulation.

[40]  P. Mozdziak,et al.  Species variations in cDNA sequence and exon splicing patterns in the extensible I-band region of cardiac titin: relation to passive tension , 2004, Journal of Muscle Research & Cell Motility.

[41]  Culprit Mechanism(s) for Exercise Intolerance in Heart Failure With Normal Ejection Fraction* , 2022 .